Stereotactic body radiation therapy versus surgical resection for stage I non–small cell lung cancer

McGarry, 2002, Observation-only management of early stage, medically inoperable lung cancer: poor outcome, Chest, 121, 1155, 10.1378/chest.121.4.1155 Raz, 2007, Natural history of stage I non-small cell lung cancer: implications for early detection, Chest, 132, 193, 10.1378/chest.06-3096 Baumann, 2008, Stereotactic body radiotherapy for medically inoperable patients with stage I nonsmall cell lung cancer—a first report of toxicity related to COPD/CVD in a nonrandomized prospective phase II study, Radiother Oncol, 88, 359, 10.1016/j.radonc.2008.07.019 Lagerwaard, 2008, Outcomes of risk adapted fractionated stereotactic radiotherapy for stage I non-small-cell lung cancer, Int J Radiat Oncol Biol Phys, 70, 685, 10.1016/j.ijrobp.2007.10.053 Onishi, 2007, Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: updated results of 257 patients in a Japanese multi-institutional study, J Thorac Oncol, 2, S94, 10.1097/JTO.0b013e318074de34 Timmerman, 2003, Extracranial stereotactic radioablation: results of a phase I study in medically inoperable stage I non-small cell lung cancer, Chest, 124, 1946, 10.1378/chest.124.5.1946 Onimaru, 2003, Tolerance of organs at risk in small-volume, hypofractionated, image-guided radiotherapy for primary and metastatic lung cancers, Int J Radiat Oncol Biol Phys, 56, 126, 10.1016/S0360-3016(03)00095-6 Uematsu, 2001, Computed tomography–guided frameless stereotactic radiotherapy for stage I non-small cell lung cancer: a 5-year experience, Int J Radiat Oncol Biol Phys, 51, 666, 10.1016/S0360-3016(01)01703-5 Goldstraw, 2007, The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM classification of malignant tumours, J Thorac Oncol, 2, 706, 10.1097/JTO.0b013e31812f3c1a Qiao, 2003, The role of radiotherapy in treatment of stage I non-small cell lung cancer, Lung Cancer, 41, 1, 10.1016/S0169-5002(03)00152-1 Kang, 2004, Single group study to evaluate the feasibility and complications of radiofrequency ablation and usefulness of post treatment position emission tomography in lung tumours, World J Surg Oncol, 2, 30, 10.1186/1477-7819-2-30 Pennathur, 2007, Radiofrequency ablation for the treatment of stage I non–small cell lung cancer in high-risk patients, J Thorac Cardiovasc Surg, 134, 857, 10.1016/j.jtcvs.2007.04.060 Sakurai, 2007, Intractable pneumothorax due to bronchopleural fistula after radiofrequency ablation of lung tumors, J Vasc Interv Radiol, 18, 141, 10.1016/j.jvir.2006.10.011 Simon, 2005, Current role of image-guided ablative therapies in lung cancer, Expert Rev Anticancer Ther, 5, 657, 10.1586/14737140.5.4.657 Yamagami, 2006, Pneumothorax as a complication of percutaneous radiofrequency ablation for lung neoplasms, J Vasc Interv Radiol, 17, 1625, 10.1097/01.RVI.0000236607.05698.4A Ginsberg, 1995, Randomized trial of lobectomy versus limited resection for T1 N0 non-small cell lung cancer. Lung Cancer Study Group, Ann Thorac Surg, 60, 615, 10.1016/0003-4975(95)00537-U Kilic, 2009, Anatomic segmentectomy for stage I non-small cell lung cancer in the elderly, Ann Thorac Surg, 87, 1662, 10.1016/j.athoracsur.2009.02.097 El-Sherif, 2006, Outcomes of sublobar resection versus lobectomy for stage I non-small cell lung cancer: a 13-year analysis, Ann Thorac Surg, 82, 408, 10.1016/j.athoracsur.2006.02.029 Birdas, 2006, Sublobar resection with brachytherapy versus lobectomy for stage Ib nonsmall cell lung cancer, Ann Thorac Surg, 81, 434, 10.1016/j.athoracsur.2005.08.052 Santos, 2003, Comparison between sublobar resection and 125Iodine brachytherapy after sublobar resection in high-risk patients with Stage I non-small-cell lung cancer, Surgery, 134, 691, 10.1016/S0039-6060(03)00327-1 Hof, 2007, Stereotactic singledose radiotherapy (radiosurgery) of early stage nonsmall-cell lung cancer (NSCLC), Cancer, 110, 148, 10.1002/cncr.22763 Allen, 2006, Morbidity and mortality of major pulmonary resections in patients with earlystage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial, Ann Thorac Surg, 81, 1013, 10.1016/j.athoracsur.2005.06.066 Harpole, 1999, Prognostic models of thirty-day mortality and morbidity after major pulmonary resection, J Thorac Cardiovasc Surg, 117, 969, 10.1016/S0022-5223(99)70378-8 Strand, 2007, Risk factors for 30-day mortality after resection of lung cancer and prediction of their magnitude, Thorax, 62, 991, 10.1136/thx.2007.079145